14818 Shares in MiMedx Group, Inc. Acquired by Teza Capital Management LLC - Defense World
| MDXG Stock | USD 7.15 0.03 0.42% |
Roughly 63% of MiMedx's investor base is looking to short. The analysis of the overall investor sentiment regarding MiMedx Group suggests that many traders are alarmed. MiMedx's investor sentiment overview provides quick insight into current market opportunities from investing in MiMedx Group. The current market sentiment, together with MiMedx's historical and current headlines, can help investors time the market. In addition, many technical investors use MiMedx Group stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
MiMedx stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of MiMedx daily returns and investor perception about the current price of MiMedx Group as well as its diversification or hedging effects on your existing portfolios.
MiMedx |
14818 Shares in MiMedx Group, Inc. Acquired by Teza Capital Management LLC Defense World
Read at news.google.com
 |
MiMedx Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards MiMedx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
MiMedx Fundamental Analysis
We analyze MiMedx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MiMedx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MiMedx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
MiMedx is currently under evaluation in price to book category among related companies. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
MiMedx Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MiMedx stock to make a market-neutral strategy. Peer analysis of MiMedx could also be used in its relative valuation, which is a method of valuing MiMedx by comparing valuation metrics with similar companies.
Peers
MiMedx Related Equities
| CVKD | Cadrenal Therapeutics | 14.63 | ||||
| CNTA | Centessa Pharmaceuticals | 6.28 | ||||
| STOK | Stoke Therapeutics | 6.10 | ||||
| NVCT | Nuvectis Pharma | 5.78 | ||||
| CGEM | Cullinan Oncology | 3.12 | ||||
| GLUE | Monte Rosa | 3.00 | ||||
| MLYS | Mineralys Therapeutics | 2.82 | ||||
| DSGN | Design Therapeutics | 2.79 | ||||
| INZY | Inozyme PharmaInc | 2.77 | ||||
| ERAS | Erasca | 1.61 | ||||
| PTGX | Protagonist Therapeutics | 1.59 | ||||
| GPCR | Structure Therapeutics | 1.30 | ||||
| KROS | Keros TherapeuticsInc | 1.21 | ||||
| CCCC | C4 TherapeuticsInc | 0.40 | ||||
| SNDX | Syndax Pharmaceuticals | 0.10 | ||||
| ZNTL | Zentalis PharmaceuticalsL | 0.75 | ||||
| IKNA | Ikena Oncology | 1.12 | ||||
| EWTX | Edgewise Therapeutics | 2.11 | ||||
| DAWN | Day One | 2.43 | ||||
| HOWL | Werewolf Therapeutics | 3.54 | ||||
| IPSC | Century Therapeutics | 3.57 |
Check out MiMedx Hype Analysis, MiMedx Correlation and MiMedx Performance. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is MiMedx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4 | Earnings Share 0.52 | Revenue Per Share 2.687 | Quarterly Revenue Growth 0.182 | Return On Assets 0.1626 |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.